Get the Stockscreener App
21.44
2.81%
-0.62
After Hours:
21.44
Caredx Inc stock is traded at $21.44, with a volume of 865.60K.
It is down -2.81% in the last 24 hours and down -3.16% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
See More
Previous Close:
$22.06
Open:
$22.28
24h Volume:
865.60K
Relative Volume:
1.07
Market Cap:
$1.15B
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-7.9703
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-9.27%
1M Performance:
-3.16%
6M Performance:
+17.16%
1Y Performance:
+115.69%
1-Day Range:
$21.15
$22.61
1-Week Range:
$21.09
$25.95
52-Week Range:
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
21.44 | 1.15B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short Interest - MarketBeat
Wells Fargo upgrades CareDx after a 30% pullback in stock - MSN
Implied Volatility Surging for CareDx (CDNA) Stock Options - MSN
CareDx guides Q4 revenue above estimates - MSN
Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength? - MSN
First Week of March 21st Options Trading For CareDx (CDNA) - Nasdaq
What is HC Wainwright's Estimate for CareDx FY2024 Earnings? - MarketBeat
CareDx Inc (CDNA) Shares Gap Down to $21.13 on Jan 16 - GuruFocus.com
CareDx, Inc Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2024 and Provides Revenue Guidance for the Year 2025 - Marketscreener.com
Wells Fargo Upgrades CareDx (CDNA) - MSN
Wells Fargo upgrades CareDx, but lowers price target - MSN
CareDx sees Q4 revenue $85M-$86M, consensus $82.16M - MSN
Wells Fargo upgrades CareDx, but lowers price target (CDNA:NASDAQ) - Seeking Alpha
CareDx (NASDAQ:CDNA) Stock Rating Upgraded by Wells Fargo & Company - MarketBeat
Breaking Down CareDx: 3 Analysts Share Their Views - Benzinga
CareDx Inc (CDNA) Trading Down 4.47% on Jan 14 - GuruFocus.com
CareDx (NASDAQ:CDNA) Trading Down 6.1%Should You Sell? - MarketBeat
CareDx (NASDAQ:CDNA) Earns Neutral Rating from HC Wainwright - MarketBeat
CareDx (NASDAQ:CDNA) Sees Large Volume IncreaseTime to Buy? - MarketBeat
CareDx anticipates 30% revenue growth in fourth quarter By Investing.com - Investing.com South Africa
CareDx anticipates 30% revenue growth in fourth quarter - Investing.com India
CareDx Announces Strong Revenue Growth and Outlook - TipRanks
CareDx Q4 Revenue Surges 30% with Record Testing Volume, Sets Ambitious 2025 Growth Target - StockTitan
Catherine Wood's Strategic Reduction in CareDx Inc Holdings - GuruFocus.com
How to Take Advantage of moves in (CDNA) - Stock Traders Daily
CareDx revises compensation policy for board members By Investing.com - Investing.com Australia
CareDx, Inc. Adopts Amendments to Outside Director Compensation PolicyOn January 6, 2025, CareDx, Inc. (NASDAQ: CDNA) made updates to its outside director compensation policy. The Compensation and Human Capital Committee of the Board of Direct - Defense World
CareDx revises compensation policy for board members - Investing.com
CareDx Updates Director Compensation and Vesting Policies - TipRanks
CareDx (NASDAQ:CDNA) Shares Up 4%Here's What Happened - MarketBeat
Natera Fails to Expand $96 Million Patent Win Over CareDx (1) - Bloomberg Law
Principal Financial Group Inc. Invests $557,000 in CareDx, Inc (NASDAQ:CDNA) - Defense World
Brokerages Set CareDx, Inc (NASDAQ:CDNA) Price Target at $29.60 - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Receives Consensus Rating of “Hold” from Brokerages - Defense World
CareDx, Inc (NASDAQ:CDNA) Short Interest Down 6.6% in December - Defense World
CareDx, Inc (NASDAQ:CDNA) Sees Large Drop in Short Interest - MarketBeat
CareDx Stock: Too Risky For Me (NASDAQ:CDNA) - Seeking Alpha
Geode Capital Management LLC Has $38.34 Million Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Geode Capital Management LLC Raises Stock Position in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx: Top Of My Shopping List For 2025 (NASDAQ:CDNA) - Seeking Alpha
Barclays PLC Acquires 54,482 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Barclays PLC Buys 54,482 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Public Employees Retirement System of Ohio Sells 38,966 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
State Street Corp Has $63.58 Million Holdings in CareDx, Inc (NASDAQ:CDNA) - Defense World
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):